Bottom line is we have two trials in Cancer and HIV that

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps
1,578
Bottom line is we have two trials in Cancer and HIV that met their primary endpoints and will get approved. We know this is true. We have one more trial in Nash that we know met it’s primary endpoint in the 350mg open trial and the blinded trial should only yield better results. This makes 3 trials that should bring us a form of approval this year. Be it a BTD or BLA that is Fast Tracked or just a full duration BLA.

How can you not love the fact that we have in the bag in my opinion 3 different indications that it’s not “if”… it’s when… we get an approval and all in this calendar year 2022. Then quite possibly we can actually get a EUA for critical this year and maybe we get another BTD in Long Haulers or if not a BTD we just receive a BLA that might be the alternative path. Either way… chalk up another winner and all in this coming year 2022. What does this make? It looks like we could see 5 approvals of some kind with maybe even one more BTD in brain metastasis. That could possibly happen this year too for 6 approvals. Is there more out there? We know there is but probably not this year unless they hope a basket trial BTD happens but not likely this calendar year.

But here we sit at .70+ and waiting for the first catalyst to pop. Waiting for the pop in stock price. When you look at the big picture is it all that bad??? Does it seem like we don’t have anything to look forward to? Hell yes we do… we need to keep our eye fixed on the goals at hand. I think it’s just about sitting back and watching good things to start happening for us. Why? Because we are overdue for good things and we have paid our dues. It’s our time no matter how you look at it. Let’s get this done this year. Let’s see these indications through to the finish line. We have hired the best CRO’s and now is the time to get a return for our investment. It’s our time!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

KULR Technology Group Achieves Record Revenue in Q3 Performance

Updated Category News Views 129

An Impressive Revenue Achievement for KULR Technology Group KULR Technology Group, Inc. (NYSE American: KULR), a leader in sustainable energy management, has reported remarkable financial results for its third quarter, showcasing a trend of consistent growth and operational improvements. As the company navigates through the fast-evolving energy landscape, it remains...

Continue Reading
Abeona Therapeutics Finalizes Agreement for $155 Million Sale

Updated Category News Views 250

Abeona Therapeutics Closes $155 Million Priority Review Voucher Deal Abeona Therapeutics Inc. (Nasdaq: ABEO) has made headlines by entering into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for an impressive $155 million. This substantial financial move marks a significant milestone for the company as they navigate the dynamics...

Continue Reading
California BanCorp's Q2 2025 Financial Results Analysis

Updated Category News Views 127

California BanCorp Reports Robust Second Quarter Earnings California BanCorp (NASDAQ: BCAL), the holding company for California Bank of Commerce, recently reported its financial performance for the second quarter, showcasing a solid net income of $14.1 million, translating to $0.43 per diluted share. Financial Highlights of Q2 2025 This impressive figure marks a decrease...

Continue Reading
Starwood Property Trust Succeeds with Private Sustainability Bond Launch

Updated Category News Views 249

Starwood Property Trust, Inc. (NYSE: STWD) completed a $400 million private offering of 6.000% unsecured senior notes due in 2030 back in early 2024, a bold move that made waves on the trading floor. Priced at par value, this maneuver was significant for traders eyeing how such issuances could affect the company’s leverage and cash flow dynamics moving forward....

Continue Reading
FrankSpeech Empowers Creators with Innovative Platform Features

Updated Category News Views 113

FrankSpeech Unveils New Features for Content Creators FrankSpeech is thrilled to announce the launch of exciting new features designed specifically for content creators. This latest initiative marks a significant advancement for the platform, focusing on enhancing video sharing, audience engagement, and monetization avenues. FrankSpeech is dedicated to creating an...

Continue Reading